Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinzhen Oral Liquid for Acute Bronchitis (China Phase II)
CTR20240615Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Feb 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Jinzhen in acute bronchitis, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Feb 2024; status: completed.
02
Drugs
Jinzhen
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20240615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240615.